http://www.nextprot.org/nanopubs#NX_P68431-1_PTM-0066_18.RAC0zjHSE_76K4zpso3hwi4EyGMc5eIj0H_23nP-xt--s
type: Nanopublication
created: 2014-09-19T00:00:00.0Z
rights: http://creativecommons.org/licenses/by/3.0/
rights holder: nextprot.org
used data: neXtProt database
authored by: CALIPHO project
authored by: http://orcid.org/0000-0001-6710-1373
authored by: 0000-0001-6818-334X
authored by: http://orcid.org/0000-0002-1303-2189
authored by: http://orcid.org/0000-0003-1813-6857
version number: 2

http://www.nextprot.org/nanopubs#NX_P68431-1_PTM-0066_18.RAC0zjHSE_76K4zpso3hwi4EyGMc5eIj0H_23nP-xt--s._2
SIO_000300: 18
type: StartPosition

http://www.nextprot.org/nanopubs#NX_P68431-1_PTM-0066_18.RAC0zjHSE_76K4zpso3hwi4EyGMc5eIj0H_23nP-xt--s._3
SIO_000300: 18
type: EndPosition

http://www.nextprot.org/nanopubs#NX_P68431-1_PTM-0066_18.RAC0zjHSE_76K4zpso3hwi4EyGMc5eIj0H_23nP-xt--s.assertion
comment: Asymmetric dimethylarginine; by CARM1; alternate modification of amino acid 18 of NX_P68431-1
evidence: gold
primary source: jbc.M410021200
primary source: science.1101400
primary source: me.2005-0365
primary source: http://www.ncbi.nlm.nih.gov/pubmed/15345777
primary source: http://www.ncbi.nlm.nih.gov/pubmed/15471871
primary source: http://www.ncbi.nlm.nih.gov/pubmed/16497732

neXtProt gold
type: ECO_0000205